1Albanese A, Barnes MP, Bhatia KP, et al. A systematic review on the diagnosis and treatment of primary ( idiopathic ) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. EurJ Neurol, 2006,13: 433-444.
2Klein C, Friedman J, Bressman S, et al. Genetic testing for earlyonset torsion dystonia ( DYT1 ) : introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test, 1999, 3:323-328 .
3Bressman SB, Sabatti C, Raymond D, et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology, 2000, 54: 1746- 1752.
4Robinson R, McCarthy GT, Bandmann O, et al. GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness. J Neurol Neurosurg Psychiatry, 1999, 66 : 86-89.
5Valente EM, Edwards MJ, Mir P, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology, 2005, 64: 737-739.
6Meunier S, Lehericy S, Gamero L, et al. Dystonia: lessons from brain mapping . Neuroscientist, 2003, 9: 76-81.
7Jankovic J. Treatment of dystonia. Lancet Neurol, 2006, 5 : 864- 872.
8Berardelli A, Abbruzzese G, Bertolasi L, et al. Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci, 1997, 18: 261-269.
9Tarsy D, Simon DK. Dystonia. N Engl J Med, 2006,355:818- 829.
10Geyer H, Bressman SB. The diagnosis of dystonia. Lancet Neurol, 2006, 5: 780-790.
9Tyler Andrew Hall Gerald McGwin Karen Searcey Aiyuan Xie Saunders L. Hupp Cynthia Owsley Lanning B. Kline 陆遥（译）.良性基础型眼睑痉挛患者与健康相关的生活质量和社会心理特征[J].美国医学会眼科杂志（中文版）,2006,18(4):256-256. 被引量：7
